The short version of anti-doping fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-09-08. Anything still debated is marked as such rather than presented as settled.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
According to CNBC and Forbes, Pansino has remained one of the highest-paid YouTubers, reporting her to have made seven figures each year through sponsorships and advertisements. Commenting on her success in an interview with Business Insider in 2014, she stated: "I've never thought about how to make a video go viral. From the very beginning I have always wanted to use YouTube to better myself and share things I enjoy with the world. If others want to join me on that journey I am happy to have them as viewers." Pansino has collaborated with several other YouTubers, including iJustine, the Merrell Twins, Rebecca Zamolo, and MatPat. She was among other YouTubers who appeared in MrBeast's 2021 "$1,000,000 Influencer Tournament". Pansino has since become critical of MrBeast due to allegations against him related to an unsafe work environment. In October 2024, she criticized the Lunchly kits for containing moldy cheese. She has been noted for her consistent upload schedule, not having missed a single date since creating her channel. She stated in an interview with Forbes that "I don't want to miss an upload; I'm just not going to do that to my community, they've shown up for me and been so supportive of me, and in exchange I've been there for them—there's always going to be a video waiting for them on Saturday.
The Greenspan lab was also involved in studies showing that mutations that affect the protease BMP-1 underlie some cases of osteogenesis imperfecta (brittle bone disease), and showing molecular mechanisms involved.
== History == After the sale of KFC in 1964, Lee Cummings (the nephew of KFC founder Colonel Harland Sanders) began developing his recipe, later to be known as "Famous Recipe." In 1966, Cummings, along with Harold Omer, started "Harold's Take-Home" in Lima, Ohio, where Cummings first introduced his Famous Recipe Chicken. Later that year, Cummings opened the restaurant's first franchise in Columbus, Ohio. Locations in Springfield, Dayton, and Cincinnati, Ohio, followed in the coming years, as well as a unit in Kalamazoo, Michigan. In 1981, Cummings sold the chain to Shoney's Restaurants in Nashville, Tennessee. He died in 2002 at the age of 80. Shoney's continued to operate Lee's along with their own Captain D's and Shoney's Restaurants until 1995, when Lee's was sold to RTM Restaurant Group in Atlanta, Georgia. In May 2003, the chain had 29 company-owned locations and 125 franchised locations. In October 2003, Lee's Famous Recipes Inc. purchased the chain from RTM. In April 2013, Famous Recipe Group LLC purchased the chain from Lee's Famous Recipes, Inc. In June 2021, Famous Recipe Group, LLC, brand owner of Lee's Famous Recipe Chicken, agreed to sell the brand to LFR Chicken, LLC a new entity backed by Artemis Lane Partners.
Sources: en.wikipedia.org
==== Waterboarding ==== Hitchens was asked by Vanity Fair to experience waterboarding for himself at a U.S. Army training facility. In May 2008, Hitchens voluntarily underwent the procedure. Hitchens stopped the procedure after 11 seconds and subsequently endorsed the view that it was "torture." He concluded, "If waterboarding does not constitute torture, then there is no such thing as torture."
=== Universities === Nilamber-Pitamber University, India National Penghu University of Science and Technology, Taiwan Northwestern Polytechnical University, China Northwestern Polytechnic University, the former name of San Francisco Bay University, California, United States North Park University, Chicago, Illinois, United States
Neuland Laboratories Limited is an Indian publicly listed contract development and manufacturing organization (CDMO) headquartered in Hyderabad. Founded in 1984, the company produces active pharmaceutical ingredients (APIs), advanced intermediates, and peptide APIs. Its shares are traded on the Bombay Stock Exchange and the National Stock Exchange.
=== Modifiable === Western pattern diet Abdominal obesity Diabetes Dyslipidemia High blood cholesterol High blood pressure Elevated concentrations of apolipoprotein B (ApoB)-containing lipoproteins (such as LDL particles), for which LDL-cholesterol (LDL-C) is the most commonly used surrogate marker High saturated fat diet Trans fat Tobacco smoking Bacterial infections HIV/AIDS Psychological stress Sedentary lifestyle
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.